Reza Shojaei/LinkedIn
May 26, 2026, 06:39
Reza Shojaei: How Neurology is Reshaping the Plasma Market?
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared a post on LinkedIn:
“Is rising demand for neurology reshaping plasma markets?
In its latest edition, ‘Blood and Plasma Pulse‘ examines how neurology affects plasma markets.
Plasma collection strategies, manufacturing expansion, supply resilience, and the future of immunoglobulin markets are highlighted in this carousel.
You can access the full newsletter here:”
Find more posts featuring Reza Shojaei on Hemostasis Today.
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients